Forensic and Scientific Services

Haymarket Media US Announces Key Leadership Transitions

Retrieved on: 
Tuesday, November 14, 2023
Social Media, Other Communications, Publishing, Finance, Public Relations, Investor Relations, Marketing, Communications, Professional Services, Maniscalco, PRI, Borella, The New York Times, Senior, CFO, NACE, Haymarket Media Group, VMLY&R, Multimedia, Compliance Week, Adviser, BAV, Advantage Business Media, COVID-19, Forensic and Scientific Services, Electronic publishing, B2C, Financial management, NewBay Media, WPP, Growth, SVP, Management, Sales

His proficiency in financial management, combined with his understanding of the industry’s dynamics, positions him as a valuable addition to the Haymarket Media US leadership team.

Key Points: 
  • His proficiency in financial management, combined with his understanding of the industry’s dynamics, positions him as a valuable addition to the Haymarket Media US leadership team.
  • “I am very excited and honored to join Haymarket Media, home to many iconic brands,” Borella said.
  • “We look forward to the valuable insights and leadership he will bring to our team.”
    In addition to naming a new CFO, Haymarket is announcing leadership changes within its PRIHealthcare Solutions (PRI) and Business Media Group divisions.
  • “I am confident that the collective expertise, vision, and dedication of our leadership team will continue to drive Haymarket Media’s success.”

The Leukemia & Lymphoma Society Honors Five Outstanding Blood Cancer Scientists with 2023 Awards

Retrieved on: 
Monday, December 11, 2023
Seattle Children's, City, ASH, Patient, Research, Biomedical Research, CRISPR, AML, Growth, Quality of life, Knowledge, LLS, Bone marrow, NCI-designated Cancer Center, Beat, Acute myeloid leukemia, Division, Dana–Farber Cancer Institute, Genome, Pancreatic serous cystadenoma, Society, DNMT3A, Face, Research institute, Lymphoma, Survivor, Network, Health, Forensic and Scientific Services, Associate, Vaccine, Chronic lymphocytic leukemia, RYE, Death, CDP, CLL, Medical device, Pharmaceutical industry, Leukemia, Medicine, Hope

Humanitarian Scientists Honored for Service to LLS, Blood Cancer Community

Key Points: 
  • Humanitarian Scientists Honored for Service to LLS, Blood Cancer Community
    The Excellence in Scientific Service award recognizes outstanding scientists who have made exceptional contributions to blood cancer research and have also generously given their time and expertise to help LLS find and fund the brightest scientists and most innovative biotech companies working to cure all forms of blood cancer.
  • "LLS is the premier organization supporting blood cancer research, and I have been privileged for the opportunity to support their efforts.
  • 2023 LLS-CDP Clinical Scholar Achievement Awardee, Matthew Davids, M.D., is Associate Professor of Medicine and Leader of the Lymphoma Program for Dana-Farber/Harvard Cancer Center.
  • LLS hosts the Research Awards & Networking Event annually timed to the American Society of Hematology (ASH) annual meeting.

Researchers Showcase Their Publications with The Scientist's Journal Club

Retrieved on: 
Monday, January 16, 2023
Molecular biology, Julian Gough (scientist), Doctor of Philosophy, Scientist, Forensic and Scientific Services, Research, Publishing, Journal club

WILMINGTON, Del., Jan. 16, 2023 /PRNewswire-PRWeb/ -- The Scientist proudly launches Journal Club, a webinar series led by our readers that connects researchers to a diverse audience of life scientists. Through Journal Club, scientists have a chance to showcase their recently-published research to The Scientist's readership.

Key Points: 
  • WILMINGTON, Del., Jan. 16, 2023 /PRNewswire-PRWeb/ -- The Scientist proudly launches Journal Club , a webinar series led by our readers that connects researchers to a diverse audience of life scientists.
  • Through Journal Club, scientists have a chance to showcase their recently-published research to The Scientist's readership.
  • The Scientist's Journal Club presents highly innovative molecular biology research conducted by members of our audience.
  • The final presentation will then appear as part of an upcoming Journal Club webinar series.

SlashNext's State of Phishing Report Reveals More Than 255 Million Attacks in 2022, Signaling a 61% Increase in Phishing Year-Over-Year

Retrieved on: 
Wednesday, October 26, 2022
Cloud, Method, LinkedIn, Forensic and Scientific Services, Health care, Software as a service, Organization, Mobile, WhatsApp, Microsoft, Technology, Gmail, AWS, Automation, Security and Trust Services API for J2ME, Report, AI, Information technology, CEO, Awareness, Personal, Face, Attack, Amazon Web Services, URL, Mobile phone, Online shopping, Google, Telegraphy

PLEASANTON, Calif., Oct. 26, 2022 /PRNewswire/ -- SlashNext, the leader in SaaS-based Integrated Cloud Messaging Security across email, web, and mobile today released the SlashNext State of Phishing Report for 2022. SlashNext analyzed billions of link-based URLs, attachments and natural language messages in email, mobile and browser channels over six months in 2022, and found more than 255 million attacks – a 61% increase in the rate of phishing attacks compared to 2021. The findings highlight that previous security strategies, including secure email gateways, firewalls, and proxy servers are no longer stopping threats, especially as bad actors increasingly launch these attacks from trusted serves and business and personal messaging apps.

Key Points: 
  • "With today's transition to hybrid working, phishing attacks are becoming more prevalent than ever," said Patrick Harr, CEO, SlashNext.
  • With new methods of phishing attacks appearing year over year, enterprises need more robust phishing protection to better protect this expanding attack surface and companies' most valuable assets."
  • Key findings of the report include:
    Cybercriminals are moving their attacks to mobile and personal communication channels to reach employees.
  • SlashNext recorded a 50% increase in attacks on mobile devices, with scams and credential theft at the top of the list of payloads.

The Scientist is proud to introduce Scientific Services

Retrieved on: 
Thursday, September 1, 2022
Professional, Technology, Research, Forensic and Scientific Services, Genetics, Doctor of Philosophy, Scientist, Molecular biology, Science, Method, Writing, Communication, News, Language, Ebook, Industry, Industrial design, Publishing

WILMINGTON, Del., Sept. 1, 2022 /PRNewswire-PRWeb/ -- The Scientist proudly launches Scientific Services, a product suite designed to help scientists showcase their research, whether through peer-reviewed journal publications, graphics and figures, or presentations and webinars.

Key Points: 
  • WILMINGTON, Del., Sept. 1, 2022 /PRNewswire-PRWeb/ -- The Scientist proudly launches Scientific Services, a product suite designed to help scientists showcase their research, whether through peer-reviewed journal publications, graphics and figures, or presentations and webinars.
  • The Scientist brand has established a tradition of excellence in scientific communication, first by covering science news for scientists, and more recently through its Creative Services Division that works with life science industrial leaders to create custom educational content for researchers.
  • Professionalism is the hallmark of Scientific Services, where a knowledgeable full-time team of PhD-trained science editors strive together with researchers to ensure that language is no obstacle.
  • Scientific Services is The Scientist's next step towards its overall goal of overcoming barriers and bringing science to its audience.

Suvoda Further Advances Mission to Reduce Friction in Complex Clinical Trials With Addition of Dr. Jill Platko as VP of Scientific Services

Retrieved on: 
Tuesday, July 12, 2022
Cornell University, NPS, Associate, Biotechnology, Leadership, Science, Information, Information technology, LinkedIn, OR, Forensic and Scientific Services, Patient, Doctor of Philosophy, Research, Genetics, Clinical data management, Guest appearance, Central nervous system, Cros, Twitter, CNS, Pharmaceutical industry, Medical device, IRT

PHILADELPHIA, July 12, 2022 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system (CNS), and rare disease, today announced the hiring of Jill Platko, PhD as Vice President of Scientific Services. Suvoda has led the way in IRT (Interactive Response Technology) development for innovative trial designs, and the addition of Dr. Platko to its team will further Suvoda's commitment to supporting pharmaceutical and biotechnology companies throughout the entire clinical trial journey for complex, life-sustaining studies.

Key Points: 
  • Dr. Platko will review the clinical protocol with customers and provide both scientific and clinical guidance on Suvoda's design and implementation.
  • "Her combination of scientific, clinical, and information technology expertise will only reinforce Suvoda's ability to deliver cutting-edge solutions designed to manage the increasing complexity of global clinical trials."
  • "I'm thrilled to have joined Suvoda just as the eCOA product is ready for early adopters," said Dr. Platko.
  • This unique approach underscores Suvoda's commitment to quality, and to me, that's exciting for the future of clinical trials."

Suvoda Further Advances Mission to Reduce Friction in Complex Clinical Trials With Addition of Dr. Jill Platko as VP of Scientific Services

Retrieved on: 
Tuesday, July 12, 2022
Cornell University, NPS, Associate, Biotechnology, Leadership, Science, Information, Information technology, LinkedIn, OR, Forensic and Scientific Services, Patient, Doctor of Philosophy, Research, Genetics, Clinical data management, Guest appearance, Central nervous system, Cros, Twitter, CNS, Pharmaceutical industry, Medical device, IRT

PHILADELPHIA, July 12, 2022 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system (CNS), and rare disease, today announced the hiring of Jill Platko, PhD as Vice President of Scientific Services. Suvoda has led the way in IRT (Interactive Response Technology) development for innovative trial designs, and the addition of Dr. Platko to its team will further Suvoda's commitment to supporting pharmaceutical and biotechnology companies throughout the entire clinical trial journey for complex, life-sustaining studies.

Key Points: 
  • Dr. Platko will review the clinical protocol with customers and provide both scientific and clinical guidance on Suvoda's design and implementation.
  • "Her combination of scientific, clinical, and information technology expertise will only reinforce Suvoda's ability to deliver cutting-edge solutions designed to manage the increasing complexity of global clinical trials."
  • "I'm thrilled to have joined Suvoda just as the eCOA product is ready for early adopters," said Dr. Platko.
  • This unique approach underscores Suvoda's commitment to quality, and to me, that's exciting for the future of clinical trials."

Red Nucleus Launches Medical Communications Business Unit

Retrieved on: 
Thursday, June 16, 2022
Medical Communications for Combat Casualty Care, Solution, RN, E-Learning Developers' Community of Practice, Industry, Drug development, Compliance, Forensic and Scientific Services, Efficiency, PPM, Medicine, United Kingdom, Red nucleus

YARDLEY, Pa., June 16, 2022 /PRNewswire-PRWeb/ -- Red Nucleus ("RN"), a premier provider of strategic learning and development, scientific services and advisory, and medical communications solutions exclusively for the life sciences industry, is pleased to announce that it is consolidating recent acquisitions to form a Medical Communications business unit.

Key Points: 
  • YARDLEY, Pa., June 16, 2022 /PRNewswire-PRWeb/ -- Red Nucleus ("RN"), a premier provider of strategic learning and development, scientific services and advisory, and medical communications solutions exclusively for the life sciences industry, is pleased to announce that it is consolidating recent acquisitions to form a Medical Communications business unit.
  • The new business unit brings together the recent acquisitions of INVIVO Communications, PPM, OrtleyBio, and most recently MMSG.
  • This alignment brings new client relationships and touchpoints across commercial and medical affairs and establishes the Medical Communications business unit as a leading digital scientific communications agency with deep therapeutic knowledge and experience integrating innovative technology into communications solutions that engage and delight.
  • Red Nucleus is a leading provider of scientific and advisory services, digital medical communications, and strategic learning and development, exclusively for the life sciences industry.